泰和诚医疗 (ccm.n)

+ 收藏

资产负债表(泰和诚医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
截止日期 2023-12-312023-06-302022-12-312022-06-30
报表类型 合并报表合并报表合并报表合并报表
报表年结日 1231123112311231
原始币种 人民币人民币人民币人民币
上市前/上市后 上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 58,139,000.00243,382,000.00158,283,000.0074,984,000.00
 受限制存款及现金流动(元) 32,280,000.0021,203,000.001,060,000.00475,000.00
 应收账款及票据(元) 73,496,000.0098,109,000.00130,271,000.0089,329,000.00
 预付款项及其他应收款流动(元) 412,946,000.00445,453,000.00385,351,000.00339,847,000.00
 存货(元) 40,347,000.0042,691,000.0084,835,000.0069,825,000.00
 短期投资(元) ---3,518,000.00
 流动资产合计(元) 617,208,000.00850,838,000.00759,800,000.00577,978,000.00
非流动资产:
 物业、厂房及设备(元) 3,546,873,000.003,262,114,000.003,259,145,000.003,223,423,000.00
 受限制存款及现金非流动(元) 4,646,000.004,645,000.008,932,000.00231,399,000.00
 无形资产(元) 323,287,000.00340,121,000.00353,766,000.00643,123,000.00
 商誉(元) 575,427,000.00575,427,000.00575,427,000.00581,877,000.00
 长期投资(元) 394,711,000.00423,059,000.00437,874,000.00424,460,000.00
 非流动资产其他项目(元) 591,791,000.00613,866,000.00609,990,000.00628,721,000.00
 非流动资产合计(元) 5,436,735,000.005,219,232,000.005,245,134,000.005,733,003,000.00
总资产(元) 6,053,943,000.006,070,070,000.006,004,934,000.006,310,981,000.00
流动负债:
 短期债务及长期负债本期部分(元) 1,042,188,000.00739,714,000.00512,583,000.00333,886,000.00
 融资租赁负债流动(元) 46,492,000.0042,606,000.0035,916,000.0023,272,000.00
 应付账款及票据(元) 129,236,000.00131,587,000.00146,748,000.00107,815,000.00
 应付税项流动(元) 1,522,000.001,696,000.00818,000.00-
 其他应付款及应计费用(元) 731,793,000.00414,746,000.00419,881,000.00348,882,000.00
 衍生工具负债流动(元) 163,000.005,562,000.005,290,000.00-
 流动负债合计(元) 1,951,394,000.001,335,911,000.001,121,236,000.00813,855,000.00
非流动负债:
 长期债务(元) 1,994,014,000.002,271,445,000.002,471,427,000.002,517,458,000.00
 融资租赁负债非流动(元) 193,007,000.00201,145,000.00199,953,000.00214,525,000.00
 衍生工具负债非流动(元) ---6,162,000.00
 递延所得税负债非流动(元) 99,538,000.00105,647,000.00112,577,000.00187,346,000.00
 非流动负债其他项目(元) 69,003,000.0067,980,000.0084,084,000.0094,925,000.00
 非流动负债合计(元) 2,355,562,000.002,646,217,000.002,868,041,000.003,020,416,000.00
总负债(元) 4,306,956,000.003,982,128,000.003,989,277,000.003,834,271,000.00
股东权益:
 普通股(元) 105,000.00105,000.00105,000.00105,000.00
 库存股(元) -7,000.00-7,000.00-7,000.00-8,000.00
 股本溢价(元) 2,007,965,000.002,026,075,000.001,930,633,000.001,928,495,000.00
 留存收益(元) -4,064,589,000.00-3,857,916,000.00-3,766,931,000.00-3,391,922,000.00
 累计其他全面收益(元) -65,419,000.00-45,137,000.00-27,766,000.00-71,385,000.00
 归属于母公司股东权益(元) -2,121,945,000.00-1,876,880,000.00-1,863,966,000.00-1,534,715,000.00
 少数股东权益(元) 3,868,932,000.003,964,822,000.003,879,623,000.004,011,425,000.00
 股东权益合计(元) 1,746,987,000.002,087,942,000.002,015,657,000.002,476,710,000.00
负债及股东权益合计(元) 6,053,943,000.006,070,070,000.006,004,934,000.006,310,981,000.00
公告日期 2024-04-192023-09-222023-04-192022-09-23
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院